Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
FEMALE
NCT06268431

Oxytocin Rest to Reduce Cesarean Delivery

Led by Christiana Care Health Services · Updated on 2024-10-17

350

Participants Needed

1

Research Sites

103 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prolonged labor is usually managed with continuous oxytocin infusion. "Oxytocin rest" has been proposed as a strategy to resolve protracted labor in patients who have received continuous oxytocin without progress. This strategy involves discontinuing oxytocin then restarting infusion after a period of time, under the theory that washout of the oxytocin receptor will strengthen uterine contractions to improve labor progress. "Oxytocin rest" is performed on labor and delivery units across the United States. Yet, there is no randomized or prospective data to support the practice. The purpose of this study is to assess whether oxytocin rest of 60 minutes in patients with prolonged labor reduces risk for cesarean delivery.

CONDITIONS

Official Title

Oxytocin Rest to Reduce Cesarean Delivery

Who Can Participate

Age: 18Years - 55Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Singleton pregnancy with the baby positioned head-down
  • Pregnancy of 36 weeks or more
  • Prolonged latent labor defined as cervical dilation less than 6 cm after at least 8 hours since rupture of membranes while on continuous oxytocin infusion
Not Eligible

You will not qualify if you...

  • Any contraindication to continuous oxytocin at the time of randomization
  • Anticipated cesarean section by the clinical team at randomization for reasons other than labor dystocia
  • More than 18 hours between rupture of membranes and randomization
  • Known intraamniotic infection at randomization
  • Fetal death
  • Any contraindication to vaginal delivery
  • Maternal eclampsia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

ChristianaCare Health System

Newark, Delaware, United States, 19718

Actively Recruiting

Loading map...

Research Team

T

Teresa C Logue

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here